Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Ashish Kumar Gupta,1 Ruchika Pokhriyal,1 Uddipan Das,1 Mohd Imran Khan,1 Domada Ratna Kumar,1 Rishab Gupta,2 Rakesh Kumar Chadda,2 Rashmi Ramachandran,3 Vinay Goyal,4 Manjari Tripathi,4 Gururao Hariprasad11Department of Biophysics; 2Department of Psychiatry; 3Department of Anaesthesia; 4Department o...

Full description

Bibliographic Details
Main Authors: Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Cerebro-spinal fluid
Parkinson’s disease
schizophrenia
dopamine
apolipoprotein E
α-synuclein
biomarkers
treatment monitoring
Online Access:https://www.dovepress.com/evaluation-of-alpha-synuclein-and-apolipoprotein-e-as-potential-biomar-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/evaluation-of-alpha-synuclein-and-apolipoprotein-e-as-potential-biomar-peer-reviewed-article-NDT

Similar Items